Alina Vrieling

6.3k total citations · 1 hit paper
70 papers, 2.3k citations indexed

About

Alina Vrieling is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Alina Vrieling has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 22 papers in Surgery and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Alina Vrieling's work include Cancer Risks and Factors (25 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Urinary and Genital Oncology Studies (16 papers). Alina Vrieling is often cited by papers focused on Cancer Risks and Factors (25 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Urinary and Genital Oncology Studies (16 papers). Alina Vrieling collaborates with scholars based in Netherlands, Germany and United States. Alina Vrieling's co-authors include Jenny Chang‐Claude, Ellen Kampman, Dieter Flesch‐Janys, Katharina Buck, Judith Heinz, Lambertus A. Kiemeney, Karen Steindorf, Martina E. Schmidt, Rudolf Kaaks and Aida Karina Zaineddin and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Alina Vrieling

66 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

2023 167 citations Lisa M.C. van Hoogstraten, Alina Vrieling et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Alina Vrieling

Since Specialization

Citations

This map shows the geographic impact of Alina Vrieling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Vrieling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Vrieling more than expected).

Fields of papers citing papers by Alina Vrieling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Vrieling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Vrieling. The network helps show where Alina Vrieling may publish in the future.

Co-authorship network of co-authors of Alina Vrieling

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Vrieling. A scholar is included among the top collaborators of Alina Vrieling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Vrieling. Alina Vrieling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer 2025 ·Cancer Causes & Control ·Alina Vrieling, (unknown), (unknown), (unknown), Katja K.H. Aben, J.P. Michiel Sedelaar, Helena Furberg, Lambertus A. Kiemeney	0
2	Associations of physical activity and sedentary time with health-related quality of life in patients with localized renal cell cancer: a cross-sectional analysis within the ReLife study 2024 ·Supportive Care in Cancer ·Alina Vrieling, (unknown), Jan W. Gerritsen, Laurien M. Buffart, Katja K.H. Aben, J.P. Michiel Sedelaar, Esmée A. Bakker, Lambertus A. Kiemeney	0
3	Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort 2023 ·European Urology Oncology ·(unknown), (unknown), Katja K.H. Aben, Jorg R. Oddens, J. Alfred Witjes, Lambertus A. Kiemeney, Alina Vrieling	3
4	Trends in Diet and Cancer Research: A Bibliometric and Visualization Analysis 2023 ·Cancers ·Erin D. Giles, Sarah A. Purcell, Jessica Olson, Alina Vrieling, Kelly A. Hirko, (unknown), Mary C. Playdon, Gwendolyn A. Thomas, L. Anne Gilmore, (unknown), Annie E. Newell‐Fugate	8
5	Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections 2023 ·Journal for ImmunoTherapy of Cancer ·Jelmer H. van Puffelen, Boris Novakovic, Liesbeth van Emst, (unknown), Tahlita C.M. Zuiverloon, (unknown), J. Alfred Witjes, Tessel E. Galesloot, Alina Vrieling, Katja K.H. Aben, Lambertus A. Kiemeney, Egbert Oosterwijk, Mihai G. Netea, Joost L. Boormans, Antoine G. van der Heijden, Leo A. B. Joosten, Sita H. Vermeulen	27
6	Cohort profile – the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands 2023 ·BMJ Open ·(unknown), J.P. Michiel Sedelaar, Katja K.H. Aben, Ellen Kampman, (unknown), Lambertus A. Kiemeney, Alina Vrieling	3
7	Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice breakdown → 2023 ·Nature Reviews Clinical Oncology ·Lisa M.C. van Hoogstraten, Alina Vrieling, Antoine G. van der Heijden, Manolis Kogevinas, Anke Richters, Lambertus A. Kiemeney	167
8	Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients 2022 ·Familial Cancer ·Meeke Hoedjes, Alina Vrieling, (unknown), A. Visser, E. Gómez, Nicoline Hoogerbrugge, Ellen Kampman	3
9	Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer – A multicenter population-based cohort study 2021 ·Clinical Nutrition ·(unknown), J.P. Michiel Sedelaar, Peter F.A. Mulders, Katja K.H. Aben, Lambertus A. Kiemeney, Alina Vrieling	20
10	The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life 2019 ·BMJ Open ·(unknown), (unknown), J. Alfred Witjes, Katja K.H. Aben, Ellen Kampman, Lambertus A. Kiemeney, Alina Vrieling	10
11	Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration 2017 ·PLoS ONE ·A. Visser, Alina Vrieling, (unknown), Nicoline Hoogerbrugge, Ellen Kampman, Meeke Hoedjes	13
12	Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial 2017 ·Clinical Genetics ·Alina Vrieling, A. Visser, Meeke Hoedjes, (unknown), E. Gómez, Nicoline Hoogerbrugge, Ellen Kampman	8
13	Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis 2016 ·European Urology Focus ·Alina Vrieling, Ellen Kampman, (unknown), Peter F.A. Mulders, J.P. Michiel Sedelaar, Vickie E. Baracos, Lambertus A. Kiemeney	55
14	The effect of smoking and timing of smoking cessation on clinical outcome in non–muscle-invasive bladder cancer 2014 ·Urologic Oncology Seminars and Original Investigations ·Anne J. Grotenhuis, (unknown), Katja K.H. Aben, J. Alfred Witjes, Alina Vrieling, Sita H. Vermeulen, Lambertus A. Kiemeney	31
15	The Association Between Dietary Lignans, Phytoestrogen-Rich Foods, and Fiber Intake and Postmenopausal Breast Cancer Risk: A German Case-Control Study 2012 ·Nutrition and Cancer ·Aida Karina Zaineddin, Katharina Buck, Alina Vrieling, Judith Heinz, Dieter Flesch‐Janys, Jakob Linseisen, Jenny Chang‐Claude	65
16	Dietary patterns and survival in German postmenopausal breast cancer survivors 2012 ·British Journal of Cancer ·Alina Vrieling, Katharina Buck, Petra Seibold, Judith Heinz, Nadia Obi, Dieter Flesch‐Janys, Jenny Chang‐Claude	58
17	Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status 2011 ·International Journal of Cancer ·Aida Karina Zaineddin, Alina Vrieling, Katharina Buck, Susen Becker, Jakob Linseisen, Dieter Flesch‐Janys, Rudolf Kaaks, Jenny Chang‐Claude	37
18	Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study 2011 ·Breast Cancer Research ·Alina Vrieling, Rebecca Hein, Sascha Abbas, Andreas Schneeweiß, Dieter Flesch‐Janys, Jenny Chang‐Claude	96
19	Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer 2011 ·British Journal of Cancer ·Katharina Buck, Aida Karina Zaineddin, Alina Vrieling, Judith Heinz, Jakob Linseisen, Dieter Flesch‐Janys, Jenny Chang‐Claude	49
20	Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC 2009 ·Cancer Causes & Control ·Eric J. Duell, Patrick Maisonneuve, Peter Baghurst, H. Bas Bueno-de-Mesquita, Parviz Ghadirian, Anthony B. Miller, Witold Zatoński, Alina Vrieling, Paolo Boffetta, Peter Boyle	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact